Insider filing · ALNY
Tolga Tanguler
EVP, Chief Commercial Officer
profile →
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · 56 filings in 24 months
ticker →
Tolga Tanguler sold $505K of Alnylam Pharmaceuticals (ALNY)
Executed Aug 18 2025, disclosed Aug 19 2025, 1 day later.
Value, as filed
$505K
1,113 sh across 3 lots
Executed
Aug 18 2025
the trade date, as filed
Disclosed
Aug 19 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TTTolga Tanguler (EVP, Chief Commercial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $607K of ALNY (1,959 sh × $310.08, as filed), executed Feb 13.
The name
ALNYHealthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Tolga Tanguler in ALNY
ALNYSALE
Alnylam Pharmaceuticals, Inc.
$361K1,117 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $236K
721 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $607K
1,959 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $262K
579 sh across 2 lots
Exec Oct 2 2025
Filed Oct 3 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $1.4M
3,135 sh across 4 lots
Exec Aug 29 2025
Filed Sep 2 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $208K
826 sh × $251.42
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET